ARIX Stock Overview
Arix Bioscience plc is a venture capital firm specializing in all stages of growth, seed stage, preclinical and clinical stage assets, startup, early stage, mid venture, late stage, growth capital investments as well as private and public equity.
Arix Bioscience plc Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||UK£1.05|
|52 Week High||UK£1.36|
|52 Week Low||UK£1.00|
|1 Month Change||-4.57%|
|3 Month Change||-11.81%|
|1 Year Change||-18.36%|
|3 Year Change||0%|
|5 Year Change||-44.86%|
|Change since IPO||-50.00%|
Recent News & Updates
|ARIX||GB Capital Markets||GB Market|
Return vs Industry: ARIX underperformed the UK Capital Markets industry which returned -8.2% over the past year.
Return vs Market: ARIX underperformed the UK Market which returned -5.9% over the past year.
|ARIX Average Weekly Movement||2.7%|
|Capital Markets Industry Average Movement||4.8%|
|Market Average Movement||5.8%|
|10% most volatile stocks in GB Market||11.2%|
|10% least volatile stocks in GB Market||2.9%|
Stable Share Price: ARIX is less volatile than 75% of UK stocks over the past 3 months, typically moving +/- 3% a week.
Volatility Over Time: ARIX's weekly volatility (3%) has been stable over the past year.
About the Company
Arix Bioscience plc is a venture capital firm specializing in all stages of growth, seed stage, preclinical and clinical stage assets, startup, early stage, mid venture, late stage, growth capital investments as well as private and public equity. The firm seeks to invest in biotech companies, novel therapeutics, innovative technologies, medical innovation comprising healthcare and life sciences. It seeks to invest globally.
Arix Bioscience plc Fundamentals Summary
|ARIX fundamental statistics|
Is ARIX overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|ARIX income statement (TTM)|
|Cost of Revenue||UK£0|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
|Earnings per share (EPS)||-0.42|
|Net Profit Margin||104.66%|
How did ARIX perform over the long term?See historical performance and comparison